Xue-fu Chen

Extended peginterferon alfa‐2a (Pegasys) therapy in Chinese patients with HBeAg‐negative chronic hepatitis B

Xiao-Jun Ma, Xiaoping Chen, Xue-fu Chen, 2014, Journal of medical virology.

Alterations in Peripheral Lymphocyte Subsets in Early Stage of Novel Coronavirus Pneumonia

Yu Zhou, Xue-fu Chen, Jing Huang, 2020, SSRN Electronic Journal.

[Study on the efficacy and HBeAg seroconversion related factors of telbivudine and entecavir therapy in HBeAg positive chronic hepatitis B patients].

Xiao-Jun Ma, Xue-fu Chen, Xiao-ping Chen, 2011, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology.

Comparison of 208‐week sequential therapy with telbivudine and entecavir in HBeAg‐positive chronic hepatitis B patients with suboptimal responses to 24 weeks of Peg‐IFNα‐2a therapy: An open‐labelled, randomized, controlled, “real‐life” trial

Y. Zhou, X. P. Chen, Xue-fu Chen, 2017, Journal of viral hepatitis.